# Sutro Biopharma

XpressCF® platform on E. coli/CHO lysate — antibodies and ADCs, reactors to thousands of litres.

Source: https://en.bioecon.ru/companies/sutro-biopharma/
Updated: 2026-06-24

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Founded | 2003 | https://ir.sutrobio.com/financials/sec-filings/content/0001193125-26-119873/stro-20251231.htm, https://www.sutrobio.com/wp-content/uploads/2020/09/World-ADC-Shabbir-Anik-Sutro-FINAL-compressed.pdf |
| Headcount | 134 (as of March 2026) | https://www.sec.gov/Archives/edgar/data/1382101/000119312526224170/R11.htm |
| Headquarters | South San Francisco, California | https://ir.sutrobio.com/financials/sec-filings/content/0001193125-26-119873/stro-20251231.htm, https://www.sutrobio.com/wp-content/uploads/2020/09/World-ADC-Shabbir-Anik-Sutro-FINAL-compressed.pdf |
| Production site | San Carlos, California (operations ceased, exit expected in 2026) | https://www.pharmamanufacturing.com/all-articles/article/55277392/sutro-to-exit-internal-gmp-manufacturing-facility-by-end-of-2025-as-part-of-restructuring |
| Capacity | Commercial scale manufacturing performed by external CMOs, such as 4,500L batches at Boehringer Ingelheim's facility | https://www.pharmamanufacturing.com/all-articles/article/55277392/sutro-to-exit-internal-gmp-manufacturing-facility-by-end-of-2025-as-part-of-restructuring, https://www.sutrobio.com/sutro-biopharma-and-boehringer-ingelheim-bioxcellence-collaboration-established-first-in-class-cell-free-capabilities-at-commercial-scale/ |

Independent sources: ir.sutrobio.com, pharmamanufacturing.com, sec.gov

## Technologies

- [Cell-free systems & cell-free bioproduction](https://en.bioecon.ru/technology/cell-free-systems-cell-free-bioproduction/)